China
Africa
Explore chapters and articles related to this topic
Amnioinfusion
Published in Hung N. Winn, Frank A. Chervenak, Roberto Romero, Clinical Maternal-Fetal Medicine Online, 2021
James Kerns, Erol Amon, Hung N. Winn
Clear evidence of impending fetal hypoxia or acidosis generally requires expedient delivery rather than temporization with amnioinfusion. Maternal exclusions include maternal heart disease (New York Heart Association functional classification II or greater), as noted by Sadovsky and colleagues due to potential fluid overload from absorption (29). Abnormal uterus such as septate uterus may be less distensible and less pliable to amnioinfusion, thus less timely change in the pressure–volume curve. Whether chorioamnionitis is a contra-indication is controversial, since some consider this condition to be an indication.
Reduction in myocardial function and oxygen consumption after chemoradiotherapy in patients with esophageal cancer
Published in Acta Oncologica, 2022
Mette Marie Astrup Søndergaard, Marianne Nordsmark, Ditte Sloth Møller, Kirsten Melgaard Nielsen, Steen Hvitfeldt Poulsen
The patients underwent two cardiac examinations at the Department of Cardiology, Aarhus University Hospital, Denmark. The baseline clinical cardiac examination was performed before dCRT or nCRT; the second cardiac examination (follow-up (F-U)) was performed within a week after CRT had been completed. The cardiac examinations comprised assessment of cardiac history; physical examination including measurement of weight, height, and biochemical testing; 12-lead electrocardiogram; comprehensive transthoracic echo (TTE) at rest and during exercise; and a symptom-limited, semi-supine cardiopulmonary exercise (CPX) test with an assessment of peak oxygen consumption (VO2max). An automatic blood pressure monitor was used to assess blood pressure during quiet resting conditions over 20 min. New York Heart Association functional classification (NYHA), Charlson Comorbidity Index (CCI), and Clinical Frailty Score were evaluated [13–15].
Expression of sex steroid receptors and aromatase in adipose tissue in different body regions in men with coronary artery disease with and without ischemic systolic heart failure
Published in The Aging Male, 2020
Elżbieta Kalicińska, Katarzyna Wojtas, Jacek Majda, Maciej Zacharski, Jacek Skiba, Jan Śliwowski, Waldemar Banasiak, Piotr Ponikowski, Ewa A. Jankowska
Inclusion criteria for group 3 were as follows: (1) LVEF ≤45% assessed by echocardiography, (2) symptoms of HF in New York Heart Association Functional Classification (NYHA) class I–III within ≥3 months preceding the study, (3) CAD confirmed by angiography (the presence at least one significant stenosis of coronary artery) and the presence of typical symptoms according to European Society of Cardiology (ESC) guidelines, and (4) clinical stability and unchanged medication within ≥1 month preceding the study. Inclusion criteria for group 2 were as follows: (1) LVEF >45% assessed by echocardiography, (2) CAD confirmed by angiography (presence at least 1 significant stenosis of coronary artery) and the presence of typical symptoms according to ESC guidelines, and (3) clinical stability and unchanged medication within ≥1 month preceding the study. Inclusion criteria for group 1 were as follows: (1) clinical stability within ≥1 month preceding the study and (2) the absence of cardiovascular disease.
Rest-activity rhythms, daytime symptoms, and functional performance among people with heart failure
Published in Chronobiology International, 2020
Sangchoon Jeon, Samantha Conley, Nancy S. Redeker
Table 1 shows the descriptive statistics for the demographic and clinical characteristics of the sample and sleep characteristics, symptoms, and functional performance. The sample included 135 participants [(Mean age = 60.6 SD = 16.1 ys); N = 88 (65.2%) male]. The majority were in class II or III of the New York Heart Association Functional Classification (87%) and had LVEF <45 (78%). The average comorbidity index was 2.4 (SD = 1.5), and half of the participants had insomnia. More than half of the participants had hypertension (57%), and some anti-hypertensive medications, including ACE Inhibitors (54.5%), angiotension receptor blockers (31.8%), and beta alpha blockers (59.1%), were used for hypertension or heart failure.